An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá.
作者信息
Arias T D, Jorge L F
出版信息
Br J Clin Pharmacol. 1989 Oct;28(4):493-4. doi: 10.1111/j.1365-2125.1989.tb03532.x.
Abstract
摘要
相似文献
1
An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá.关于异喹胍和鹰爪豆碱代谢模式种族独特性的观察：对巴拿马恩加韦瓜伊米美洲印第安人的一项研究。
Br J Clin Pharmacol. 1989 Oct;28(4):493-4. doi: 10.1111/j.1365-2125.1989.tb03532.x.
2
3
A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.关于斯巴丁在恩加韦·瓜伊米美洲印第安人中的瞬时多态性氧化的初步说明：一个具有该途径暂定系统发育时间框架的遗传分化案例。
Clin Pharmacol Ther. 1988 Sep;44(3):343-52. doi: 10.1038/clpt.1988.160.
4
The debrisoquine/sparteine oxidation polymorphism: evidence of genetic heterogeneity among Ghanaians.去甲丙咪嗪/鹰爪豆碱氧化多态性：加纳人基因异质性的证据。
Prog Clin Biol Res. 1986;214:189-206.
5
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.司巴丁N-氧化缺陷与异喹胍4-羟化的药物遗传学共变。
Eur J Clin Pharmacol. 1980 Feb;17(2):153-5. doi: 10.1007/BF00562624.
6
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities.鹰爪豆碱和异喹胍的多态性氧化：相关药物遗传学实体。
Clin Pharmacol Ther. 1982 Feb;31(2):184-6. doi: 10.1038/clpt.1982.29.
7
Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.奎尼丁：体内对司巴丁和异喹胍氧化有强效抑制作用。
Br J Clin Pharmacol. 1986 Aug;22(2):199-200. doi: 10.1111/j.1365-2125.1986.tb05251.x.
8
Comparative pharmacogenetics of sparteine and debrisoquine.鹰爪豆碱和异喹胍的比较药物遗传学
Clin Pharmacol Ther. 1983 Mar;33(3):394-9. doi: 10.1038/clpt.1983.51.
9
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.运用分析双峰分布的新方法对人司巴丁和异喹胍代谢的遗传控制。
J Med Genet. 1983 Oct;20(5):321-9. doi: 10.1136/jmg.20.5.321.
10
Deficient metabolism of debrisoquine and sparteine.异喹胍和鹰爪豆碱代谢缺陷。
Clin Pharmacol Ther. 1980 Apr;27(4):547-9. doi: 10.1038/clpt.1980.77.
引用本文的文献
1
Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.中美洲和加勒比地区的药物遗传学研究活动：一项系统综述。
Pharmacogenomics. 2016 Oct;17(15):1707-1724. doi: 10.2217/pgs-2016-0053. Epub 2016 Sep 16.
2
Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.巴拿马库纳美洲印第安人中异喹胍代谢率的单峰分布。
Br J Clin Pharmacol. 1990 Aug;30(2):281-5. doi: 10.1111/j.1365-2125.1990.tb03776.x.
本文引用的文献
1
Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation.尼日利亚人美托洛尔和异喹胍的代谢：缺乏多态性氧化的证据。
Clin Pharmacol Ther. 1986 Oct;40(4):387-94. doi: 10.1038/clpt.1986.195.
2
On phenotyping with isoniazid: the use of urinary acetylation ratio and the uniqueness of antimodes. Study of two Amerindian populations.关于异烟肼表型分析：尿乙酰化率的应用及双峰的独特性。对两个美洲印第安人群的研究。
Clin Pharmacol Ther. 1987 Nov;42(5):493-7. doi: 10.1038/clpt.1987.186.
3
A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.关于斯巴丁在恩加韦·瓜伊米美洲印第安人中的瞬时多态性氧化的初步说明：一个具有该途径暂定系统发育时间框架的遗传分化案例。
Clin Pharmacol Ther. 1988 Sep;44(3):343-52. doi: 10.1038/clpt.1988.160.
4
The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.巴拿马库纳美洲印第安人中司巴丁的氧化代谢：缺乏代谢缺陷者的证据
Clin Pharmacol Ther. 1988 Apr;43(4):456-65. doi: 10.1038/clpt.1988.58.
Zotero 插件